Drag a card by its title · ⚙ to size, swap or remove

The company

Travere Therapeutics, Inc.

TVTX · Nasdaq

Health CareBiotechnologySetting up

TVTX stood above a rising 150-day average in 45 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 3.1% below that average now. Biotechnology: 17% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 27% (−6 points in four weeks).

SEC filings

Statistics

Last close, 23 Oct 2026: 50.08 −4.48%
52-week range: —
Volume: 2.31M
Average volume (50 days): —
Relative volume: —
Rotation: Setting up
Weeks in an uptrend: out for 2
Industry in uptrend: 17% -9 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $210.3M
Officials’ trades on record: 0
Institutions holding: 294 (+49)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 45 of 52 weeks.

24 Apr – 23 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Price and volume

Daily bars to 23 Oct 2026: 30 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months80

Buyers · sellers0 · 11

Who	Did	Shares	Traded
Eric M. DubeCHIEF EXECUTIVE OFFICER	sold	128,065at $52.97	15 Oct 2026filed 19 Oct 2026
Eric M. DubeCHIEF EXECUTIVE OFFICER	sold	37,270at $54.20	15 Oct 2026filed 19 Oct 2026
Eric M. DubeCHIEF EXECUTIVE OFFICER	sold	78,400at $55.02	15 Oct 2026filed 19 Oct 2026
Eric M. DubeCHIEF EXECUTIVE OFFICER	sold	101,691at $64.59	17 Sep 2026filed 17 Sep 2026
Eric M. DubeCHIEF EXECUTIVE OFFICER	sold	6,802at $64.95	17 Sep 2026filed 17 Sep 2026
Peter HeermaEVP, CHIEF COMMERCIAL OFFICER	sold	8,282at $65.07	17 Sep 2026filed 17 Sep 2026
William E. RoteChief Research Officer	sold	65,104at $63.12	16 Sep 2026filed 17 Sep 2026
William E. RoteChief Research Officer	sold	47,746at $63.61	16 Sep 2026filed 17 Sep 2026
Eric M. DubeCHIEF EXECUTIVE OFFICER	sold	99,716at $63.26	16 Sep 2026filed 17 Sep 2026
Eric M. DubeCHIEF EXECUTIVE OFFICER	sold	96,125at $63.64	16 Sep 2026filed 17 Sep 2026
Peter HeermaEVP, CHIEF COMMERCIAL OFFICER	sold	93,604at $63.25	16 Sep 2026filed 17 Sep 2026
Peter HeermaEVP, CHIEF COMMERCIAL OFFICER	sold	79,113at $63.65	16 Sep 2026filed 17 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders294+49 on the quarter

New · exited81 · 32

Reported value$5.9B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Jupiter Topco LLCnew · filed 14 Aug 2026	11,324,191$643.3M	+11,324,191
BlackRock, Inc.added · filed 7 Aug 2026	8,020,663$455.7M	+228,630+2.9%
FMR LLCreduced · filed 13 Aug 2026	7,096,614$403.2M	-3,871,353−35.3%
BANK OF AMERICA CORPadded · filed 14 Aug 2026	4,568,341$259.5M	+3,223,230+239.6%
STATE STREET CORPreduced · filed 7 Aug 2026	4,256,224$241.8M	-703,764−14.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,108,694$233.4M	+62,882+1.6%
PERCEPTIVE ADVISORS LLCreduced · filed 14 Aug 2026	3,752,574$213.2M	-389,977−9.4%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.reduced · filed 14 Aug 2026	2,812,514$159.8M	-457,999−14.0%
ADAGE CAPITAL PARTNERS GP, L.L.C.added · filed 14 Aug 2026	2,569,356$146.0M	+1,592,356+163.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026	2,371,887$134.8M	+2,328+0.1%